Product Review - Brexpiprazole for the treatment of schizophrenia

This review discusses the evidence in support of the use of brexpiprazole, its pharmacology including its mechanism of action, and efficacy and tolerability as demonstrated in pivotal clinical trials. It also provides commentary and recommendations from Professor Nicholas Alexander Keks, Professor of Psychiatry at Monash University and a psychiatrist in private practice at Delmont Private Hospital.

Please login below to download this issue (PDF)

Subscribe